Repligen
RGEN
#2045
Rank
โ‚น834.85 B
Marketcap
โ‚น14,831
Share price
-0.47%
Change (1 day)
23.11%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น187.26 Billion

According to Repligen 's latest financial reports the company has โ‚น187.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น169.23 B3.46%
2023-12-31$โ‚น163.57 B3.45%
2022-12-31$โ‚น158.11 B21.38%
2021-12-31$โ‚น130.25 B16.48%
2020-12-31$โ‚น111.83 B47.98%
2019-12-31$โ‚น75.57 B75.58%
2018-12-31$โ‚น43.04 B13.96%
2017-12-31$โ‚น37.77 B229.35%
2016-12-31$โ‚น11.46 B40.59%
2015-12-31$โ‚น8.15 B15.19%
2014-12-31$โ‚น7.08 B10.33%
2013-12-31$โ‚น6.41 B39.34%
2012-12-31$โ‚น4.60 B
2011-03-31$โ‚น2.98 B1.12%
2010-03-31$โ‚น2.94 B-15.59%
2009-03-31$โ‚น3.49 B35.99%
2008-03-31$โ‚น2.56 B133%
2007-03-31$โ‚น1.10 B-3.3%
2006-03-31$โ‚น1.14 B7.94%
2005-03-31$โ‚น1.05 B-10.34%
2004-03-31$โ‚น1.17 B0.91%
2003-03-31$โ‚น1.16 B-9.55%
2002-03-31$โ‚น1.29 B-10.41%
2001-03-31$โ‚น1.44 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novavax
NVAX
-โ‚น14.09 Billion-107.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น544.47 B 190.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น270.01 B 44.19%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.709 T 813.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.598 T 2,355.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.672 T 792.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น8.368 T 4,369.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น176.71 B-5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น0.56 B-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น310.21 B 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA